Generic name |
denosumab |
Strength |
60 mg |
Form |
subcutaneous injection |
Special Authority criteria |
Approval period |
AND with clinical or radiographically documented fracture due to osteoporosis AND for whom oral bisphosphonates are contraindicated for one of the following reasons:
OR
|
Indefinite |
|
5 years |